It is no secret that in the context of corporate philanthropy in the field of health care, significant contributions are seen mostly as gestures aimed at helping create elite research facilities or private pavilions. For instance, the belief that when a famous billionaire decides to donate a large amount of money to a medical institution, his/her main purpose is to advance biomedical research becomes very popular.